Fernando Anaya

1.4k total citations
40 papers, 702 citations indexed

About

Fernando Anaya is a scholar working on Transplantation, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Fernando Anaya has authored 40 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Transplantation, 9 papers in Psychiatry and Mental health and 8 papers in Surgery. Recurrent topics in Fernando Anaya's work include Renal Transplantation Outcomes and Treatments (11 papers), Alzheimer's disease research and treatments (7 papers) and Dementia and Cognitive Impairment Research (5 papers). Fernando Anaya is often cited by papers focused on Renal Transplantation Outcomes and Treatments (11 papers), Alzheimer's disease research and treatments (7 papers) and Dementia and Cognitive Impairment Research (5 papers). Fernando Anaya collaborates with scholars based in Spain, United States and Germany. Fernando Anaya's co-authors include Merçé Boada, Isabel Hernández, Domingo del Castillo, Laura Núñez, Javier Olazarán, Juan Berenguer, Antonio Páez, María Luisa Rodríguez-Ferrero, Oscar L. López and Mireia Torres and has published in prestigious journals such as Kidney International, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

Fernando Anaya

38 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Anaya Spain 13 221 152 125 117 107 40 702
Enikő Sárváry Hungary 14 44 0.2× 164 1.1× 113 0.9× 154 1.3× 81 0.8× 62 641
Hartmut Dietrich Germany 16 34 0.2× 89 0.6× 134 1.1× 130 1.1× 70 0.7× 40 655
Ido Laish Israel 12 96 0.4× 202 1.3× 50 0.4× 173 1.5× 116 1.1× 46 797
Wolfgang Erwa Austria 21 202 0.9× 147 1.0× 43 0.3× 102 0.9× 401 3.7× 37 1.1k
Hannu Jokela Finland 18 98 0.4× 105 0.7× 36 0.3× 246 2.1× 67 0.6× 40 894
Mladen Knotek Croatia 13 168 0.8× 99 0.7× 27 0.2× 107 0.9× 151 1.4× 45 719
D. Rae Australia 9 62 0.3× 61 0.4× 42 0.3× 196 1.7× 94 0.9× 14 564
George Dikdan United States 17 125 0.6× 220 1.4× 41 0.3× 366 3.1× 126 1.2× 33 836
Hiroaki Ikesue Japan 15 206 0.9× 53 0.3× 17 0.1× 131 1.1× 143 1.3× 69 988
D Naidoo Australia 12 29 0.1× 74 0.5× 51 0.4× 53 0.5× 58 0.5× 22 511

Countries citing papers authored by Fernando Anaya

Since Specialization
Citations

This map shows the geographic impact of Fernando Anaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Anaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Anaya more than expected).

Fields of papers citing papers by Fernando Anaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Anaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Anaya. The network helps show where Fernando Anaya may publish in the future.

Co-authorship network of co-authors of Fernando Anaya

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Anaya. A scholar is included among the top collaborators of Fernando Anaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Anaya. Fernando Anaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anaya, Fernando, et al.. (2025). Minimally Invasive Achilles Tendon Repair: Dresden vs PARS/Knotless Techniques in a Retrospective Comparative Study. Foot & Ankle International. 46(9). 951–957.
2.
Pérez‐Rus, Gloria, et al.. (2022). Plasma exchange as an effective salvage therapy in AZD1222 vaccine-induced thrombotic thrombocytopenia: a case report.. PubMed. 20(2). 152–155. 1 indexed citations
3.
Cuello, Juan Pablo, et al.. (2020). Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response. Neurological Sciences. 41(9). 2569–2574. 4 indexed citations
4.
Valerio, Maricela, Marina Machado, Santiago Cedeño, et al.. (2018). Donor-derived invasive aspergillosis after kidney transplant. Medical Mycology Case Reports. 22. 24–26. 3 indexed citations
6.
Galán, Isabel, Pablo Demelo‐Rodríguez, María Luisa Rodriguez Ferrero, & Fernando Anaya. (2015). Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia. Journal of clinical lipidology. 9(5). 698–702. 21 indexed citations
7.
Bouza, Emilio, María Guembe, Mercedes Marín, et al.. (2013). Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter–related bloodstream infection. Diagnostic Microbiology and Infectious Disease. 78(3). 316–319. 22 indexed citations
8.
Bielsa, Isabel, Gemma Cuberas‐Borrós, Lluís Tárraga, et al.. (2012). P3‐403: Longitudinal neuroimaging analysis in Alzheimer's disease after plasma exchange with 5% Grifols albumin (Albutein®). Alzheimer s & Dementia. 8(4S_Part_16). 1 indexed citations
9.
Ferrero, María Luisa Rodriguez, David Arroyo, Nayara Panizo, et al.. (2012). Monitoring of Circulating Antibodies in a Renal Transplantation Population: Preliminary Results. Transplantation Proceedings. 44(9). 2548–2550. 3 indexed citations
10.
Moreso, Francesc, Natalia Calvo, Julio Pascual, et al.. (2010). Early statin use is an independent predictor of long-term graft survival. Clinical Kidney Journal. 3(suppl 2). ii26–ii31. 7 indexed citations
11.
Anaya, Fernando. (2010). [Therapeutic plasmapheresis and experience in Alzheimer's disease].. PubMed. 50 Suppl 5. S5–8. 2 indexed citations
12.
Rodríguez-Ferrero, María Luisa, Jara Ampuero, & Fernando Anaya. (2009). Rituximab and Chronic Plasmapheresis Therapy of Nephrotic Syndrome in Renal Transplantation Patients With Recurrent Focal Segmental Glomerulosclerosis. Transplantation Proceedings. 41(6). 2406–2408. 27 indexed citations
13.
Boada, Merçé, et al.. (2009). Amyloid-targeted therapeutics in Alzheimer's disease: Use of human albumin in plasma exchange as a novel approach for abeta mobilization. Drug News & Perspectives. 22(6). 325–325. 91 indexed citations
14.
Morales, J.M., Roberto Marcén, Amado Andrés, et al.. (2008). Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease. Kidney International. 74(111). S94–S99. 40 indexed citations
15.
Anaya, Fernando, et al.. (2008). Ezetimibe in the Treatment of Uncontrolled Hyperlipidemia in Kidney Transplant Patients. Transplantation Proceedings. 40(10). 3492–3495. 5 indexed citations
16.
Catalina, María‐Vega, Jésus Barrio, Fernando Anaya, et al.. (2003). Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver International. 23(s3). 39–43. 58 indexed citations
17.
Íñigo, Pablo, Josep M. Campistol, Ramón Saracho, et al.. (2003). Renoprotective Effects of Losartan in Renal Transplant Recipients. Nephron Clinical Practice. 95(3). c84–c90. 28 indexed citations
18.
Anaya, Fernando, et al.. (2001). Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation. Nephrology Dialysis Transplantation. 16(suppl_1). 117–120. 26 indexed citations
19.
Berenguer, Juan, et al.. (1998). Visceral Leishmaniasis in a Renal Transplant Recipient. American Journal of Nephrology. 18(2). 171–171. 11 indexed citations
20.
Berenguer, Juan, et al.. (1998). VISCERAL LEISHMANIASIS (KALA-AZAR) IN TRANSPLANT RECIPIENTS. Transplantation. 65(10). 1401–1404. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026